Pyoderma
3
Pipeline Programs
4
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
2
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
JSC Valenta PharmaceuticalsRussia - Moscow
1 program1
HydroxymethylquinoxalindioxydePhase 31 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
MSDsisomicin
JSC Valenta PharmaceuticalsHydroxymethylquinoxalindioxyde
Clinical Trials (2)
Total enrollment: 240 patients across 2 trials
Sisomicin Cream Vs Nadifloxacin Cream in Primary Pyodermas (Study P04460)
Start: May 2007Est. completion: Sep 20070
Phase 4Withdrawn
Efficacy and Safety of Dioxidin Versus Miramistin in Superficial Pyoderma
Start: Jul 2022Est. completion: Dec 2022240 patients
Phase 3Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs, potential near-term approvals
4 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.